Experimenters hope to harness the powerful effects of medications such as Ozempic and Wegovy at doses smaller than those studied most.
of U.S. adults take GLP-1 drugs. But not all of them are taking full doses. Around one in seven users has “microdosed” injections, a recent survey by the health tracking app Evidation found. Some take tiny portions for practical reasons, such as cutting costs.
Others have loftier ambitions: They hope to harness the drugs’ powerful effects to achieve better health and longer lives without losing a lot of weight or experiencing side effects such as, which helps regulate appetite, metabolism and blood sugar. That has made the drugs blockbuster treatments for type 2 diabetes and obesity. But to date, “there is no rigorous scientific data to support microdosing,” says bariatric medicine specialist Katy Williams of the University of Missouri Health Care in Jefferson City.explicitly sell GLP-1 microdoses There is some research to suggest GLP-1s can promote healthy aging by improving overall health. The drugs have been found toBut science hasn’t caught up to the hype. There’s scant published research on GLP-1 microdosing, although some teams are studying it. For instance, a low dose of the active ingredient in Ozempic and Wegovy . And AgelessRx is starting a clinical trial focused on how GLP-1 microdosing affects health and quality of life. Some people aren’t waiting around for data. That includes many patients of Shamsah Amersi, an ob-gyn in Santa Monica, Calif. Amersi discusses microdosing with all patients entering perimenopause, she says, and about 60 percent of her patients over 40 use one. Amersi claims that the majority of microdosers under her care feel better and see improvements on lab tests measuring metabolic and overall health. “GLP-1 is one of the most transformative therapies in modern medicine,” she says, though she notes the drugs are not for everyone. Amersi thinks patients can benefit from microdosing now, even without data to prove its efficacy, if they work with a doctor to carefully monitor their response. Other experts remain wary. There isn’t enough data to confirm that microdosing can help you live longer, says clinical pharmacist practitioner Anne Komé of the University of North Carolina Medical Center in Chapel Hill, who published a 2025. But it could help clinicians optimize therapy for patients who have trouble affording the drugs or who struggle with gastrointestinal issues or other side effects, she says. All medications come with potential risks and side effects. It’s not worth taking that chance when benefits are unproven, Williams says. She’d rather longevity seekers focus on diet, exercise and sleep.as major drug manufacturers are. Customers can’t always be sure that what’s on the label matches what’s in the vial. “Save your money,” Williams says.
United States Latest News, United States Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
Ozempic-Like Drugs May Help Prevent Damage After a Heart AttackThe Best in Science News and Amazing Breakthroughs
Read more »
Ozempic, Wegovy are getting generics as low as $15 around the world — what it means for AmericansToday's Video Headlines: 03/19/26
Read more »
FDA approves high-dose Wegovy shotsU.S. regulators on Thursday approved a new higher-dose version of the blockbuster obesity drug Wegovy. The Food and Drug Administration approved a 7.2-milligram dose of Novo Nordisk's semaglutide. Previously, the highest approved dose of the drug, taken as a weekly injection, was 2.4 milligrams.
Read more »
FDA Approves Higher Dose of Wegovy for Weight LossThe FDA has approved a new, higher dose of Wegovy, a medication used for weight loss. The new dose is 7.2 milligrams, significantly higher than the previous maximum of 2.4 milligrams. This higher dose showed improved weight loss results in clinical trials but also increased the likelihood of side effects.
Read more »
Fast-track FDA approval brings stronger Wegovy to pharmacies by AprilJustin Boggs is a writer for the E.W. Scripps company. Justin covers anything from politics to sports and entertainment.
Read more »
Ozempic copies for $14 as the generic GLP-1 era starts in IndiaIndian drugmakers begin selling generic Ozempic copies at $14 monthly Friday — 88% cheaper than Novo's brand-name version.
Read more »